At a time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical ...

Pharma companies lobby for changes to Medicare drug price rules, targeting a four-year delay for pills' eligibility. Critics ...

President-elect Donald Trump’s nomination of Robert F. Kennedy Jr. to helm the Department of Health and Human Services(HHS) ...

Seven lobbyists and executives who work with top pharmaceutical and biotech companies told Reuters they are pushing to delay ...

When it comes to weeding out corporate influence, Robert F. Kennedy Jr.’s ideas often align best with some of Trump’s loudest ...

Big Pharma allows millions of people to alleviate debilitating pain, manage dangerous and chronic diseases, mitigate their ...

Some of the world's largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the ...

Hospitals account for about 30% of the $4.5 trillion the U.S. spends annually on healthcare, compared with 9% for drugs.

Mark Cuban (entrepreneur, investor, and founder, Cost Plus Drugs) joins Chris Cuomo to discuss disrupting Big Pharma, ...

Despite billions poured into research, new medicines still typically take a decade or more to develop.

By late November, pharma groups such as Eli Lilly, Novartis and Vertex Pharmaceuticals had completed a total of 558 deals globally, worth a combined value of $67.2bn, the lowest level for that stage ...